CVC Capital Partners and other private equity owners are exploring options for generic drugmaker Alvogen, including a sale, which could be valued at about $4 billion, Bloomberg reported on Tuesday.
Apollo funds complete minority investment in Alpine-backed Apex Service Partners
11 hours ago · 2 mins read
Rainier Partners invests in Texas auto insurance MGA platform Apex
17 hours ago · 2 mins read
Stonepeak completes carve-out of BMO’s transportation and vendor finance units
17 hours ago · 2 mins read
Trivest-backed Wheelhouse buys California and Utah garage door firm All Star
17 hours ago · 1 min read
Water Street and JLL Partners’ Eversana announces acquisition of London’s Estima Scientific
19 hours ago · 1 min read
DPE’s Mehler Systems to acquire majority stake in Bulgaria’s MARS Armor
20 hours ago · 1 min read
Speyside Equity buys Midwest steel tubing and building products maker Tapco
29 October 2026 · 2 mins read
